Industrial Microbiology Market Report 2026

The industrial microbiology market size has grown strongly in recent years. It will grow from $16.53 billion in 2025 to $17.75 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing use of microbes in industrial production, expansion of food and beverage safety testing, rising pharmaceutical manufacturing activity, growing environmental monitoring needs, availability of standardized microbiology equipment.

The industrial microbiology market size is expected to see strong growth in the next few years. It will grow to $24.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing demand for bio-based industrial products, rising adoption of automation in laboratories, expansion of biopharmaceutical manufacturing, growing focus on sustainable production processes, increasing regulatory emphasis on microbial quality control. Major trends in the forecast period include increasing adoption of automated microbial testing systems, rising demand for industrial fermentation applications, growing focus on sustainable bio-based production, expansion of microbial quality testing services, enhanced use of data analytics in microbiology.

Rising pharmaceutical production is expected to drive the expansion of the industrial microbiology market in the coming years. Pharmaceutical production refers to the manufacture of medicines and therapeutic products through chemical synthesis, biological methods, or biopharmaceutical techniques. The growth in pharmaceutical production can be linked to several factors, such as an aging population, regulatory developments, and health crises that increase the demand for medications and innovative therapies. Industrial microbiology utilizes microbial fermentation processes to produce pharmaceuticals on a large scale, including antibiotics such as penicillin, vaccines, and hormones like insulin, by using microorganisms such as bacteria, yeast, and fungi. For example, in April 2025, Eurostat, a Luxembourg-based government agency, reported that in 2024, EU exports of medicinal and pharmaceutical products rose by 13.5% compared with 2023, reaching $316.38 billion (€313.4 billion). Meanwhile, imports increased only slightly by 0.5%, totaling $112.7 billion (€119.7 billion). Therefore, the rise in pharmaceutical production is driving the growth of the industrial microbiology market.

Major companies operating in the industrial microbiology market are concentrating on developing innovative solutions, such as rapid microbial screening technologies, to speed up quality control processes and enhance operational efficiency. Rapid microbial screening technologies allow quicker detection of microbial contamination, minimizing product hold times and enabling high-throughput testing to improve productivity and product safety. For example, in October 2023, Hygiena, a US-based food safety diagnostics company, introduced the RapiScreen Beverage Kit, an advanced microbial screening solution designed for industrial microbiology applications in the beverage industry. The RapiScreen Beverage Kit employs ATP bioluminescence technology to rapidly identify microbial contamination in low-pH beverages, including fruit juices, teas, energy drinks, UHT-pasteurized products, and smoothie mixes. It provides quality control results in less than 30 minutes following a brief incubation period, compared with conventional culture methods that may require 4-10 days, and supports the testing of up to 96 samples at once, enabling quicker product release, lower storage costs, better inventory turnover, and improved safety and profitability in manufacturing operations.

In January 2024, Novozymes A/S, a Denmark-based biotechnology company, merged with Chr. Hansen Holding A/S to form Novonesis, a global biosolutions partner. Through this merger, Novozymes and Chr. Hansen established Novonesis as a leading global biosolutions organization focused on utilizing microbiology and biology-based innovations to support sustainable growth, improve business performance, and generate positive outcomes for people and the planet. Chr. Hansen Holding A/S is a Denmark-based biotechnology company.

Major companies operating in the industrial microbiology market include Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., The Merck Group, Becton Dickinson and Company, Asiagel Corporation, Eppendorf Group, bioMérieux SA, Novamed Ltd., QIAGEN N.V., Sartorius AG, 3M Company, Agilent Technologies Inc., vermicon AG, Eurofins Scientific SE, MilliporeSigma, Hardy Diagnostics, Neogen Corporation, HiMedia Laboratories, BioConnections, Biomerica Inc., Bruker Corporation, Charles River Laboratories International Inc., GENEWIZ Inc., Luminex Corporation, Microbiologics Inc., Promega Corporation, Q Laboratories Inc., Rapid Micro Biosystems Inc., Shimadzu Corporation, TSI Incorporated

North America was the largest region in the industrial microbiology market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global industrial microbiology market report during the forecast period. The regions covered in the industrial microbiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the industrial microbiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The industrial microbiology market consists of revenues earned by entities by providing services such as production hygiene and final product testing, preservation system design and evaluation, testing and validation of disinfectants and treated articles, and efficacy data generation for product registration. The market value includes the value of related goods sold by the service provider or included within the service offering. The industrial microbiology market also includes sales of slides, test tubes, petri dishes, solid and liquid growth mediums, inoculation loops, pipettes and tips, incubators, autoclaves, and laminar flow hoods, which are used in providing industrial microbiology services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.